Detalles de la búsqueda
1.
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Lancet
; 396(10247): 333-344, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32738955
2.
Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.
BMC Cancer
; 18(1): 784, 2018 Aug 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30075763
3.
Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study.
PLoS Med
; 12(1): e1001780, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634542
4.
Selective LC-MS/MS method for the identification of BMAA from its isomers in biological samples.
Anal Bioanal Chem
; 403(6): 1719-30, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22526645
5.
High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.
Health Technol Assess
; 24(10): 1-54, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090730
6.
Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
Lancet Gastroenterol Hepatol
; 2(1): 23-31, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28404010
Resultados
1 -
6
de 6
1
Próxima >
>>